Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

Discover how Professor Shabir Madhi is advancing maternal vaccines to safeguard newborns from RSV, GBS, and more.

A group of mothers in Victoria say they've experienced trouble accessing the jab for a highly infectious illness that infects ...

It is a mistake to claim that there is not widespread research into the effectiveness of vaccines, especially those given to ...

Medical staff in Western Australia have been warned after reports of the wrong immunisations being given to patients.

A particular area of concern is the threat of RSV for African American babies. Since Black women have the highest rate of premature births (18.3%), this means nearly 100,000 Black babies are born ...

Merck & Co., Inc. (NYSE: MRK) is one of the. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for ...

The WA Department of Health has sent an urgent reminder to medical staff to make sure they’re giving patients the right RSV ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

The newly appointed US Advisory Committee on Immunization Practices (ACIP) has announced two working groups that will review the US children’s vaccination schedule. Opening the first ACIP meeting ...